100% of patients treated with ketamine demonstrated reduction in dyskinesias as measured by the Unified Dyskinesia Rating Scale
— Read on financialpost.com/globe-newswire/pharmather-announces-positive-topline-results-from-clinical-study-of-ketamine-for-parkinsons-disease